Serum soluble syndecan-1 levels at diagnosis constitute an independent
prognostic factor of survival in myeloma that may further differentiate
patients within the ISS stages
Serum soluble syndecan-1 levels at diagnosis constitute an independent prognostic factor of survival in myeloma that may further differentiate patients within the ISS stages
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Έτος δημοσίευσης:
2005
Συγγραφείς:
Kyrtsonis, MC Vassilakopoulos, TP Papadogiannis, A Tzenou, T and Kalpadakis, C Antoniadis, A Dimopoulou, MN Siakantaris, MP Kokoris, SI Dimitriadou, EM Angelopoulou, MK Plata, E and Tsaftaridis, P Pangalis, GA
